Triple-negative breast cancer (TNBC) is an aggressive subtype comprising about 10–20% of
breast cancer patients with an overall poor prognosis. Recently, it was found to be a …

Metastatic triple-negative breast cancer (TNBC) is a distinct and immensely complex form of
breast cancer. Among all subtypes of breast cancers, TNBC has a comparatively high rate of …

Background: The development of advanced treatment of triple-negative breast cancer
(TNBC) is the utmost need of an era. TNBC is recognized as the most aggressive, metastatic …

Abstract Purpose of Review Triple-negative breast cancer (TNBC) accounts for 15–20% of
diagnosed breast tumours, with higher incidence in young and African-American women …

Triple-negative breast cancer (TNBC) is associated with an increased risk of early
recurrence and distant metastasis, as well as the development of therapeutic resistance and …

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer and is
associated with high probability of metastasis and poor prognosis. Chemotherapeutics and …

The evolution of therapeutics for triple-negative-breast cancer (TNBC) has been lagging
behind in comparison to that of other breast cancer subtypes. This review focuses on the …

Triple negative breast cancer (TNBC) is a subtype of breast tumor which comprises 24% of
newly diagnosed tumors that lacks hormone receptor expression and HER2 gene …

Triple-negative breast cancer (TNBC) is the most aggressive type of cancer, with a high risk
of death on recurrence. To date, there is a lack of approved targeted agents for the treatment …

Overview Triple negative breast cancer (TNBC) comprises 12–20% of all breast cancers and
are a heterogeneous group of tumors, both clinically and pathologically. These cancers are …